Eric Levkosky and Tempus Labs

CEO and tech entreprenuer Eric Lefkovsky is a man who has made his name as someone who really makes things happen, to say the least. He has many successful startup companies to his credit, including Groupon and Echo Global Logistics, but now with Tempus Labs, he is venturing into an area in which he has a passionate personal interest.

Tempus Labs, of which Lefkovsky is the founder and CEO, is now rated as one of the top health tech labs in Chicago. Tempus was created to create collaboration between top academic institutions and NCI-designated centers for cancer research. The goal for Lefkovsky is to use Tempus to create a platform for personalized cancer care so that optimal cancer treatments can be provided to all who need it.

An Inspiration

Lefkovsy has always used his curiosity and tech savvy to develop his companies and to push past perceived limitations. He became inspired to create Tempus Labs when he saw the huge gap there was in communications in the field of cancer care. Though there is a huge amount of data that has been collected from patients who are dealing with the illness, the problem was in putting that information in a place where it was readily accessible to physicians. Without access to patient data, doctors have been facing delays in providing the treatment that is needed. The goal, for Tempus Labs (and Lefkofsky), is to bring all the available patient clinical records and molecular date together in one place. Doing this could be a ground breaking move in creating more personalized care for cancer patients,

An Educator And Philanthropist

Eric Lefkovsky brings his background as an entrepreneur but also as an educator (he is currently an adjunct professor at the University of Chicago’s Booth School of Business) and a philanthropist (he, along with his wife, created the Lefkovsky Family Foundation which supports the arts, medicine and culture). There’s no doubt Lefkovsky is working with all he has to improve lives by supporting developments in cancer research, and with Tempus Labs, there’s every possibility that he will.

For details:

Eric Lefkofsky Startup Tempus to Help in Cancer Fight

Technology company Tempus, founded in 2015 by Eric Lefkofsky, wants to provide doctors at the University of Chicago data to assist in treatment of patients with breast cancer.Tempus has announced a partnership with the University of Chicago Medicine to provide molecular sequencing and analysis to breast cancer specialists to help them tailor individualized treatment plans for patients. Tempus will analyze data from about 1,000 breast cancer patients to assist in uncovering patterns to predict how patients will respond to treatment.Tempus uses machine learning and genomic sequencing to help with the treatment plans. The goal is for this information to lead to better treatment and patient outcomes.

Dr. Olufunmilayo Olopade, professor of medicine and human genetics and dean for global health at the University of Chicago, said in a statement that specific genetic data could help physicians make better informed and targeted treatment decisions.In recent months, Tempus has entered into partnerships with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, the Mayo Clinic, Rush University Medical Center, Penn Medicine and the University of Michigan to use information to battle cancer.In addition to acting as the CEO of Tempus, Eric Lefkofsky is also a founding partner of Lightbank and the co-founder and Chairman of Groupon, Mediaocean, Echo Global Logistics and InnerWorkings.

In 2006 Eric Lefkofsky established the Lefkofsky Family Foundation, a charitable foundation to advance high-impact initiatives that enhance lives in the communities served. Among other positions, Lefkofsky serves as a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago. He is an adjunct professor at the University of Chicago and author of Accelerated Disruption. He graduated from the University of Michigan in 1991 and received his Juris Doctor from the University of Michigan Law School in 1993.